Select Language:
A research team from the University of Auckland is investigating a promising new medication that could offer relief for individuals living with both heart failure and sleep apnea. Although the drug is still undergoing testing, early results indicate it may enhance breathing during sleep and lessen the stress on the heart. If future research confirms these benefits, a single pill could potentially treat two major health issues simultaneously.
Heart failure is a chronic condition where the heart becomes either too weak or too stiff to effectively circulate blood throughout the body. While the heart doesn’t stop functioning entirely, it can’t deliver sufficient oxygen and nutrients to meet the body’s demands. Symptoms often include fatigue, weakness, shortness of breath, and swelling in the legs, ankles, or feet caused by fluid buildup. Globally, millions are affected, and it remains a leading cause of hospitalization among older adults.
Sleep apnea is another prevalent condition characterized by repeated pauses in breathing during sleep. These interruptions lower oxygen levels and disrupt normal sleep cycles, even if the individual isn’t fully waking up. People with sleep apnea often snore loudly, wake up gasping for air during the night, or feel extremely tired during the day due to poor quality sleep.
Although these conditions seem different, scientists have discovered a close connection between them. Individuals with heart failure are much more likely to develop sleep apnea, and if left untreated, sleep apnea can worsen heart failure. Fragmented sleep and low oxygen levels add extra strain to the heart, forcing it to work harder.
Researchers believe that this link may partly stem from an overactive “fight or flight” response—the body’s natural reaction to danger, which increases heart rate and blood pressure. In healthy individuals, this response turns off once the threat is gone. However, in many with heart failure, the system remains active constantly, causing ongoing stress that can damage the heart and contribute to breathing issues during sleep.
The new drug, called AF-130, aims to calm this hyperactive response. By reducing unnecessary nerve activity, it may help individuals breathe more normally at night and decrease the strain on the heart. The hope is that this could improve sleep quality, enhance cardiac function, and boost overall well-being.
Currently, the primary treatment for sleep apnea involves a CPAP machine, which gently delivers air through a mask to keep the airway open. While effective for many, some find the device uncomfortable or hard to use consistently. An oral medication that improves sleep apnea without requiring a machine could provide an alternative for those patients.
Additionally, AF-130 is being considered for approval by the U.S. Food and Drug Administration for another medical condition, which could facilitate further clinical trials to assess its safety and effectiveness in treating both heart failure and sleep apnea.
For now, AF-130 remains experimental. More studies involving human participants are necessary to determine its efficacy, optimal dosage, and possible side effects. Nonetheless, this research offers hope that future treatments might address multiple health concerns with a single medication.
If you’re interested in heart health, you should learn about how herbal supplements could interfere with heart rhythm, and how incorporating eggs into your diet might help reduce your risk of heart disease. Other recent findings include that apple juice could have benefits for heart health and that consuming yogurt might lower mortality risks among those with heart conditions.
Copyright © 2026 Knowridge Science Report. All rights reserved.
